ArticleCardiovascular diabetology2021

Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.

Yuze Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.